ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,677Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 783

$915K Total Retail Price of All Prescriptions

Rank: 63 out of 783

543 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 543 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

25% of this provider’s 543 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 14,417 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LISINOPRIL 1,156 840 1 4
OMEPRAZOLE 924 697 2 6
SIMVASTATIN 775 561 3 3
HYDROCODONE-ACETAMINOPHEN 763 431 S3 4 2
FUROSEMIDE 640 441 5 7
LEVOTHYROXINE SODIUM 622 511 6 1
AMLODIPINE BESYLATE 575 522 7 5
WARFARIN SODIUM 475 323 8 10
POTASSIUM CHLORIDE 465 342 9 16
GABAPENTIN 401 233 10 15
METFORMIN HCL 382 267 11 8
HYDROCHLOROTHIAZIDE 297 255 12 12
ATENOLOL 296 192 13 17
TRAMADOL HCL 281 226 14 20
METOPROLOL SUCCINATE 275 221 15 13
METOPROLOL TARTRATE 274 212 16 9
LOSARTAN POTASSIUM 236 224 17 18
ALLOPURINOL 229 172 18 31
RANITIDINE HCL 213 129 19 44
CLOPIDOGREL 203 172 20 29
GLIMEPIRIDE 201 175 21 34
DIOVAN 199 195 22 49
LANTUS 195 134 23 38
CLONIDINE HCL 177 156 24 60
PAROXETINE HCL 176 159 25 69
ENALAPRIL MALEATE 160 143 26 68
ATORVASTATIN CALCIUM 155 145 27 11
BYSTOLIC 153 153 28 99
JANUVIA 151 126 29 73
KLOR-CON M20 146 105 30 48
PRAVASTATIN SODIUM 146 97 30 14
INSULIN SYRINGE 136 77 32 82
ROPINIROLE HCL 126 76 33 74
PLAVIX 120 93 34 51
ALENDRONATE SODIUM 119 94 35 25
DONEPEZIL HCL 117 109 36 24
AMOXICILLIN 116 77 37 116
PREDNISONE 104 96 38 36
ZOLPIDEM TARTRATE 103 81 39 23
DILTIAZEM 24HR CD 102 90 40 118
SERTRALINE HCL 99 53 41 22
MECLIZINE HCL 97 55 42 146
FAMOTIDINE 94 87 43 55
PROAIR HFA 93 56 44 56
HUMALOG 88 53 45 101
CRESTOR 87 83 46 27
CEPHALEXIN 87 56 46 70
METHYLPREDNISOLONE 87 72 46 138
AZITHROMYCIN 87 64 46 41
ISOSORBIDE MONONITRATE ER 86 62 50 40
CYCLOBENZAPRINE HCL 85 25 R 51 63
TAMSULOSIN HCL 85 84 51 26
PANTOPRAZOLE SODIUM 85 56 51 30
NAPROXEN 83 55 54 104
CITALOPRAM HBR 83 46 54 19
KLOR-CON 10 82 61 56 102
LEVOFLOXACIN 79 57 57 75
PROMETHAZINE HCL 79 42 R 57 97
ACETAMINOPHEN-CODEINE 78 56 S3 59 144
NEXIUM 77 42 60 28
SPIRIVA 76 70 61 59
DIGOXIN 75 69 62 61
CARVEDILOL 74 66 63 21
DIPHENOXYLATE-ATROPINE 73 21 64 266
ADVAIR DISKUS 73 56 64 50
POLYETHYLENE GLYCOL 3350 72 40 66 43
TRICOR 72 25 66 134
CIPROFLOXACIN HCL 69 51 68 62
VENLAFAXINE HCL ER 68 45 69 100
DOXYCYCLINE HYCLATE 66 31 70 112
CARBIDOPA-LEVODOPA 65 59 71 88
SYNTHROID 63 37 72 47
NAMENDA 62 62 73 32
NOVOLOG 61 30 74 81
SPIRONOLACTONE 60 43 75 57
LANTUS SOLOSTAR 60 43 75 91
HYDRALAZINE HCL 59 39 77 78
ESCITALOPRAM OXALATE 59 40 77 54
FLUOXETINE HCL 55 31 79 45
PROPRANOLOL HCL 53 53 80 129
PEN NEEDLE 51 41 81 103
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 7, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.